Kuaishou’s Q4 revenue growth slows to 8.7%: report - The Tamesis

This figure is slightly lower than market expectations of RMB 35.7 billion (US$5 billion).

Post Views: 60

Tags

Related Posts

Global healthcare PE hits $191b in 2025, report says

January 16, 2026

The ML3 status for BPOM is seen to accelerate market growth and exports.

January 15, 2026

6MM macrophage activation syndrome market eyes 24.7% CAGR growth until 2034

January 14, 2026

The Tamesis

Leave a Reply Cancel reply

Latest from Blog

After an Earthquake, Preserving a Slow Craft in a Fast World

Dress Code: Gabriella Khalil Never Shies Away From a Power Outfit

Ralph Lauren Fall 2026 Menswear Collection

Plan C Fall 2026 Ready-to-Wear Collection

The forecast covers newly diagnosed incidence from 2024 to 2034.

The Bride Wore Her Great-Grandmother’s Diamond Necklace for Her Winter Wedding at the Musée Rodin in Paris

At A$AP Rocky’s Album Release, Rihanna Offers a Lesson in Dressing for Your Partner’s Work Party

$53.6m health plan speeds up patient discharge in Queensland hospitals

Uma Wang Fall 2026 Menswear Collection

Gordon Parks Foundation Marks 20th Anniversary

Related Posts

Global healthcare PE hits $191b in 2025, report says

January 16, 2026

The ML3 status for BPOM is seen to accelerate market growth and exports.

January 15, 2026

6MM macrophage activation syndrome market eyes 24.7% CAGR growth until 2034

January 14, 2026

Don't Miss

Global healthcare PE hits $191b in 2025, report says

Europe, North America and Asia-Pacific led

The ML3 status for BPOM is seen to accelerate market growth and exports.

BPOM’s ML3 status is expected to